Stratifying Stage and Risk for Glaucoma Utilizing Pivotal Studies in Glaucoma to Manage Patients | ASCRS
Presentation
Stratifying Stage and Risk for Glaucoma Utilizing Pivotal Studies in Glaucoma to Manage Patients
May 2019
Meeting: 2019 Annual Meeting
Session: SYM-303: Glaucoma Essentials
Presenter: Douglas J. Rhee, MD
You must be logged in to view this content

This resource is only available for ASCRS Members. Please log in using the teal "Login" button in the top right-hand corner to log in.

This presentation reviews the relevant outcomes of the many prospective randomized controlled trials in glaucoma to provide the learner the best evidenced based treatment rationales based on the patient's stage of disease. Review of the staging of glaucoma severity will also be covered.
View More Presentations From SYM-303

This presentation is from the session "SYM-303: Glaucoma Essentials" from the 2019 ASCRS Annual Meeting held on May 4-7, 2019 in San Diego, California.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.